Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions

L. A. Schwiebert, L. A. Beck, C. Stellato, C. A. Bickel, B. S. Bochner, R. P. Schleimer

Research output: Contribution to journalArticle

Abstract

We believe that there are the following four classes of glucocorticoid- sensitive cytokines that are involved in cell recruitment: (1) those that activate endothelium nonspecifically; (2) those that activate endothelium specifically; (3) those that activate, prime, and prolong the survival of eosinophils; and (4) those that stimulate movement of cells up into the epithelium. Glucocorticoids inhibit the generation of these cytokines and thereby prevent several different aspects of inflamation, including the activation and recruitment of inflammatory cells (eosinophils, basophils, and lymphocytes) and the release of inflammatory mediators. We believe such pleiotropic actions account for the efficacy and widespread use of glucocorticoids in the treatment of asthma.

Original languageEnglish (US)
Pages (from-to)143-152
Number of pages10
JournalThe Journal of Allergy and Clinical Immunology
Volume97
Issue number1 II
DOIs
StatePublished - 1996

Fingerprint

Anti-Allergic Agents
Glucocorticoids
Cytokines
Eosinophils
Endothelium
Basophils
Cell Movement
Asthma
Epithelium
Lymphocytes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Schwiebert, L. A., Beck, L. A., Stellato, C., Bickel, C. A., Bochner, B. S., & Schleimer, R. P. (1996). Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions. The Journal of Allergy and Clinical Immunology, 97(1 II), 143-152. https://doi.org/10.1016/S0091-6749(96)80214-4

Glucocorticosteroid inhibition of cytokine production : Relevance to antiallergic actions. / Schwiebert, L. A.; Beck, L. A.; Stellato, C.; Bickel, C. A.; Bochner, B. S.; Schleimer, R. P.

In: The Journal of Allergy and Clinical Immunology, Vol. 97, No. 1 II, 1996, p. 143-152.

Research output: Contribution to journalArticle

Schwiebert, LA, Beck, LA, Stellato, C, Bickel, CA, Bochner, BS & Schleimer, RP 1996, 'Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions', The Journal of Allergy and Clinical Immunology, vol. 97, no. 1 II, pp. 143-152. https://doi.org/10.1016/S0091-6749(96)80214-4
Schwiebert, L. A. ; Beck, L. A. ; Stellato, C. ; Bickel, C. A. ; Bochner, B. S. ; Schleimer, R. P. / Glucocorticosteroid inhibition of cytokine production : Relevance to antiallergic actions. In: The Journal of Allergy and Clinical Immunology. 1996 ; Vol. 97, No. 1 II. pp. 143-152.
@article{df1049d4795d4393bebe9b6927401fbf,
title = "Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions",
abstract = "We believe that there are the following four classes of glucocorticoid- sensitive cytokines that are involved in cell recruitment: (1) those that activate endothelium nonspecifically; (2) those that activate endothelium specifically; (3) those that activate, prime, and prolong the survival of eosinophils; and (4) those that stimulate movement of cells up into the epithelium. Glucocorticoids inhibit the generation of these cytokines and thereby prevent several different aspects of inflamation, including the activation and recruitment of inflammatory cells (eosinophils, basophils, and lymphocytes) and the release of inflammatory mediators. We believe such pleiotropic actions account for the efficacy and widespread use of glucocorticoids in the treatment of asthma.",
author = "Schwiebert, {L. A.} and Beck, {L. A.} and C. Stellato and Bickel, {C. A.} and Bochner, {B. S.} and Schleimer, {R. P.}",
year = "1996",
doi = "10.1016/S0091-6749(96)80214-4",
language = "English (US)",
volume = "97",
pages = "143--152",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "1 II",

}

TY - JOUR

T1 - Glucocorticosteroid inhibition of cytokine production

T2 - Relevance to antiallergic actions

AU - Schwiebert, L. A.

AU - Beck, L. A.

AU - Stellato, C.

AU - Bickel, C. A.

AU - Bochner, B. S.

AU - Schleimer, R. P.

PY - 1996

Y1 - 1996

N2 - We believe that there are the following four classes of glucocorticoid- sensitive cytokines that are involved in cell recruitment: (1) those that activate endothelium nonspecifically; (2) those that activate endothelium specifically; (3) those that activate, prime, and prolong the survival of eosinophils; and (4) those that stimulate movement of cells up into the epithelium. Glucocorticoids inhibit the generation of these cytokines and thereby prevent several different aspects of inflamation, including the activation and recruitment of inflammatory cells (eosinophils, basophils, and lymphocytes) and the release of inflammatory mediators. We believe such pleiotropic actions account for the efficacy and widespread use of glucocorticoids in the treatment of asthma.

AB - We believe that there are the following four classes of glucocorticoid- sensitive cytokines that are involved in cell recruitment: (1) those that activate endothelium nonspecifically; (2) those that activate endothelium specifically; (3) those that activate, prime, and prolong the survival of eosinophils; and (4) those that stimulate movement of cells up into the epithelium. Glucocorticoids inhibit the generation of these cytokines and thereby prevent several different aspects of inflamation, including the activation and recruitment of inflammatory cells (eosinophils, basophils, and lymphocytes) and the release of inflammatory mediators. We believe such pleiotropic actions account for the efficacy and widespread use of glucocorticoids in the treatment of asthma.

UR - http://www.scopus.com/inward/record.url?scp=0030061138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030061138&partnerID=8YFLogxK

U2 - 10.1016/S0091-6749(96)80214-4

DO - 10.1016/S0091-6749(96)80214-4

M3 - Article

C2 - 8568145

AN - SCOPUS:0030061138

VL - 97

SP - 143

EP - 152

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1 II

ER -